|
| |
Dr. Ken Harvey:
Books
 | PHARM Evaluation Sub-committee
(Gilbert A, Brooks C, Corti B, Harvey K, Harvey R, James M,
Murray M, Primrose J, Swift D.) Manual of Indicators to measure
the effect of initiatives under the Quality Use of Medicine arm
of the National Medicinal Drug Policy. Australian Government
Publishing Service, Canberra 1995. |
| Harvey KJ (Chairman), Beavis M,
Christiansen K, Collignon P, Currie B, Dartnell J, Ferguson J,
Harkness J, Isaacs D, Khariwala B, Kucers A, Looke D, Spicer WJ,
Tosolini FA, Turnidge J. Antibiotic Guidelines 10th Ed.
Therapeutic Guidelines Ltd., Melbourne 1998 (and Ed 1-6). |
| Roughead EE, Gilbert AL, Primrose JG, Harvey KJ, Sansom
LN, Report of the national indicators: Evaluating the quality use
of medicines component of Australia's National Medicines Policy.
Publications Production Unit, Commonwealth Department of Health
and Aged Care, Canberra, 1999. |
Book chapters
| Harvey K, Murray M. Medicinal
drug policy, in The Politics of Health, 2nd Ed., Gardner H (Ed)
Churchill Livingstone, Melbourne, 1995, 238-283. |
| Harvey KJ. Drug Promotion, in
Drugs in the Health Marketplace. Komesaroff PA, Wiltshire J. (Ed)
Arena Publications, Melbourne 1997, 47-70. |
| Aroni R, de Boer R, Harvey K. The Viagra Affair. In
Evidence-based Health Policy, Edited by Lin V & Gibson B.
Oxford University Press, Melbourne 2003, 97-109. |
| Löfgren H, Harvey K. The
Pharmaceutical Benefits Scheme, in Understanding the Australian
Health Care System, Willis E, Reynolds L, Keleher H. (Ed)
Churchill Livingstone Elsevier, Sydney 2008. |
Editorials
| King K, Harvey K. MRSA
Revisited (Editorial). Med J Aust 1985; 2: 88-89. |
| Darvall L, Harvey KJ Australian
pharmaceutical advertising: a critique (Editorial). Medical
Journal of Australia 1985; 2:272-274. |
| Harvey K. Quality assurance of
therapeutic products and practice (Editorial). Med J Aust 1987;
147: 317. |
| Harvey K, Rogers S, Roughead L. Initiatives to improve
antibiotic use. Aust Presc 1999; 22: 26-28 (Editorial) |
Articles in
refereed journals
| Harvey KJ, Smith DD.
Antimicrobial sensitivity patterns as a guide to the domiciliary
treatment of urinary tract infections. Med J Aust 1972; 1: 177-8.
|
| Harvey KJ. Antibacterial
activity in urine. Med J Aust 1972; 1: 1072-4. |
| Bell SM, Harvey KJ, Smith DD
Double-blind trial comparing trimethoprim-sulphamethoxazole
(Bactrim) with ampicillin in treating urinary infections. Med J
Aust 1972; 1: 442. |
| Harvey KJ, Were M, Heys, Wendy,
Smith DD. A time-shared computer system for data processing in
bacteriology. Med J Aust 1972; 2: 1076. |
| Murnaghan GF, Tynan AP,
Farnsworth RH, Harvey K. Chronic prostatitis--an Australian view.
Br J Urol 1974 ;46:55-59. |
| Harvey K, Bishop L, Silver D,
Jones T. A case of chancroid. Med J Aust 1977; 1:956-957. |
| Harvey K, Schuck S.
Acinetobacter septicaemia following prolonged intravenous
therapy. Med J Aust 1977; 2:121-124. |
| Harvey KJ, Miles H, Hurse A,
Carson M. In-vitro activity of erythromycin against anaerobic
microorganisms. Med J Aust 1981; 1: 474-475. |
| Harvey K, Pavillard R.
Methicillin resistance in Staphylococcus aureus with particular
reference to Victorian strains. Med J Aust 1982 May 29; 465-7.
|
| Pavillard R, Harvey K, Douglas
D, Hewstone A, Andrew J, Collopy B, Asche V, Carson P, Davidson
A, Gilbert G, Spicer J, Tosolini F. Epidemic of hospital-acquired
infection due to methicillin-resistant Staphylococcus aureus in
major Victorian hospitals. Med J Aust 1982; 1: 451-454. |
| Harvey K. Promotion of newer
antimicrobial agents. Med J Aust 1983; 1: 27-8; |
| Harvey K, Stewart R, Hemming M,
et al. Use of antibiotic agents in a large teaching hospital. The
impact of Antibiotic Guidelines. Med J Aust 1983; 2: 217-2. |
| Harvey KJ, Stewart R, Hemming
M, Naismith N, Moulds RF. Educational antibiotic advertising. Med
J Aust 1986; 1: 28-32. |
| Avorn J, Harvey K, Soumerai SB,
et al. Information and education as determinants of antibiotic
use: Report of Task Force 5. Rev Infect Dis 1987; Suppl 3:
S286-96. |
| Graves SR, Rosengren NJ,
Kennelly-Merrit SA, Harvey KJ, Thornton IW. Antibiotic-resistance
patterns and relative concentrations of bacteria (gram-negative
rods) from ash deposits of various ages on the Krakatau islands.
Philos Trans R Soc Lond B Biol Sci 1988; 322: 327-37. |
| Landgren FT, Harvey KJ,
Mashford ML, et al. Changing antibiotic prescribing by
educational marketing. Med J Aust 1988; 149: 595-9. |
| Harvey KJ. Antibiotic use in
Australia. Aust Presc 1988; 11: 74-77. |
| Harvey K. Australia:
Pharmaceutical Benefits Scheme. Lancet 1991; 337: 418-419. |
| De Santis G, Harvey KJ, Howard
D, et al. Improving the quality of antibiotic prescriptions in
general practice. The role of educational intervention. Med J
Aust 1994; 1: 502-5. |
| Williams D, Chiu E, Harvey K.
Does admission to a hospital geriatric psychiatry programme
improve benzodiazepine and other drug use? Int J Geriatr Psychiat
1994; 9: 501-505. |
| Roughead EE, Gilbert AL, Harvey
KJ. Self-regulatory codes of conduct: are they effective in
controlling pharmaceutical representatives' presentations to
general medical practitioners? Int J Health Serv 1998; 28:
269-279. |
| Roughead EE, Harvey KJ, Gilbert
AL. Commercial detailing techniques used by pharmaceutical
representatives to influence prescribing. Aust NZ J Med 1998; 28:
306-310. |
| Nolan AM, Norquay CA, Dartnell
JGA, Harvey KJ. Electronic prescribing and computer-assisted
decision support systems. MJA 1999; 171: 541-543. |
| Harvey K. Medication management
2000: e-Scripts, e-Promotion. e-Health? Health Issues 2000; 63:
10-14. |
| Harvey Ken. Australian e-Health
Policy: Once was Rational? Health Issues 2001: 67; 11-14. |
| Roughead EE, Monteith GR,
Harvey KJ and Tett SE. Evaluating Australia's National Medicines
Policy using Geographical Mapping. Internal Medicine Journal.
2002: 3; 66-72. |
| Harvey Ken. The Pharmaceutical
Benefits Scheme Under Threat. Health Issues 2002: 71; 11-16.
|
| Phanouvong S, Barraclough S,
Harvey K. Improving primary health care in Thailand: The role of
the National Medicinal Drug Policy. Aust J Primary Health 2002:
8; 24-30. |
| Harvey K, Dartnell J, Hemming
M. Improving antibiotic use: 25 years of antibiotic guidelines
and related initiatives. Commun Dis Intell 2003; 27 Suppl
S9-S11. Available:
http://tinyurl.com/22fkkx |
| Lewis B, Harvey K, Dartnell J,
Shepheard J. Modelling and encoding Therapeutic Guidelines:
applying ICD-10-AM and European Article Number codes. Health
Information Management 2004; 32: 51-58. |
| Harvey KJ, Faunce FA, Lokuge ,
Drahos P. Will the Australia-United States Free Trade
Agreement undermine the Pharmaceutical Benefits Scheme? MJA 2004;
181: 256-259. Available:
http://www.mja.com.au/public/rop/ausfta/har10408_fm.html
|
| Harvey K, Kalanj K and
Stevanovi R. Croatian Pharmaceutical Sector Reform Project:
Rational Drug Use. CMJ 2004; 45: 611-619. Available at:
http://www.cmj.hr/2004/45/5/15495290.pdf
|
| Harvey K. Patents, pills and
politics: the Australia-United States Free Trade Agreement and
the Pharmaceutical Benefits Scheme. Aust Health Rev 2004; 28 (2):
218-226. |
| Harvey KJ. The Pharmaceutical
Benefits Scheme 2003-2004. Australia and New Zealand Health
Policy 2005, 2:2. Available:
http://www.anzhealthpolicy.com/content/2/1/2
|
| Harvey KJ, Vitry AI, Roughead
E, et al. Pharmaceutical advertising in prescribing software: an
analysis. MJA 2005; 183: 75-79. Available:
http://www.mja.com.au/public/issues/183_02_180705/har10263_fm.html
|
| Bader R, Mawajdeh S, Harvey K.
Workshop boosts rational use activities in Jordan. WHO Essential
Drugs Monitor 2005; 34: 22-23. |
| Zhang Y, Harvey KJ. Rational
antibiotic use in China: lessons learnt through introducing
surgeons to Australian guidelines. Australia and New Zealand
Health Policy 2006; 3 :5-17. Available:
http://www.anzhealthpolicy.com/content/3/1/5
|
| Harvey K. Pharmaceutical Advertisements in Prescribing
Software: What Should be Done? Health Issues, 2006; 87: 11-15.
http://www.healthissuescentre.org.au/docs/jaharvey87.pdf
Faunce
TA, Lofgren H, Harvey K, Johnston K. Tendering for Low Cost
Generics in Australia. Health Issues, 2006; Number 87: 26-29.
http://www.healthissuescentre.org.au/docs/jafaunce87.pdf
|
| Harvey K. Changes in Pharmaceutical Policy over the last
20 Years. Health Issues 2006; 89: 32-38. |
| Harvey KJ, Harris AH, Bulfone L. The National Health Amendment (Pharmaceutical Benefits Scheme) Bill 2007: reform or fracture?
MJA 2007; 187 (4): 206-207. http://www.mja.com.au/public/issues/187_04_200807/har10641_fm.html
|
| Harvey KJ, Korczak VS, Marron LJ, Newgreen DB. Commercialism,
choice and consumer protection: regulation of complementary
medicines in Australia. MJA 2008; 188 (1): 21-25.
http://www.mja.com.au/public/issues/188_01_070108/har10522_fm.html
|
| Harvey KJ. Does CM regulation need reform? J Comp Med 2008;
7(3): 37. |
| Harvey K. Australian Complementary Medicine Regulation: Time
for Reform! Health Issues 2008: 95; 18-22. |
Commissioned reports
| Harvey K, Clark R. A Mechanism
for the Development, Implementation and Evaluation of
Evidence-Based, Best-Practice Clinical Guidelines to Facilitate
Quality Use of Pathology Tests. The Quality Use of Pathology
Committee (QUPC), 2003.
http://tinyurl.com/yqteps |
| Harvey K. A Process for
Developing Evidence Based Treatment Guidelines. Report 6.4,
Reform of the Croatian Pharmaceutical Sector Project, Ministry of
Health of the Republic of Croatia & Australian Health
Insurance Commission, 2003. |
| Harvey K. Linking Therapeutic
Guidelines with the Primary Health Care Information Technology
Project. Report 6.5 Reform of the Croatian Pharmaceutical Sector
Project, Ministry of Health of the Republic of Croatia &
Australian Health Insurance Commission, 2003. |
| Victorian Hospitals Electronic
Prescribing and Decision Support Group (Harvey K, Editor).
Electronic Medication Management. Victorian Drug Usage Advisory
Committee, Melbourne, 2003.
http://tinyurl.com/3bn4zw |
| Harvey K. Guidelines for
Assessing Future Projects under the Quality Use of Pathology
(QUP) Program. Commonwealth Department of Health & Aging,
2004. |
| Harvey K. Deliverable 5:
Methodology for the Development of Standard Treatment Guidelines.
Jordan Health Sector Reform Project, Jordan Food & Drug
Administration & Australian Health Insurance Commission,
2004. |
| Harvey K. Deliverable 9: Study
of Prescribing Practices. Jordan Health Sector Reform Project,
Jordan Food & Drug Administration & Australian Health
Insurance Commission, 2004. |
| Harvey K, McCauley V, MacIsaac
P, Lewis B. Refinement of the HL7 Australia EDS Work plan: A
report for the Australian Health Information Council Electronic
Decision Support Steering Committee. HL7 Australia 2004. |
| Harvey K. Critical assessment
of Jordan RDU EDL within the International context. ,
PHRplus, Amman, Jordan, August 2005. |
| Medicare Australia Consultancy. An Economic & Equity
Impact Review of National Pharmaceutical System Models.
Pharmaceutical Reform Working Group Steering Committee, 2006.
|
Conference
proceedings &/or presentations
| Harvey K. Pharmaceutical
marketing, in Prescription for change. Philippines Centre for
Investigative Journalism & Dag Hammarskjöld Foundation,
Manila, 1992; 27-31. |
| Harvey K. Therapeutic
Guidelines - The Way Ahead. Aust Prescr 1993; 16: 13-16 (Suppl.
3). |
| Harvey, K. The National Manual
of QUM Indicators. Pharmaceutical Education Program, 1995 Work in
Progress Conference Proceedings, Commonwealth Department of
Health and Family Services, 1996, 14. |
| Harvey, K. The way forward.
Pharmaceutical Education Program, 1995 Work in Progress
Conference Proceedings, Commonwealth Department of Health and
Family Services, 1996, 36. |
| Harvey K, Nolan A, Dartnell J.
Deconstructing Therapeutic Guidelines: from printed books to
computerised decision support systems. ASCEPT conference
proceedings, Canberra, 1997. |
| Norquay C, Dartnell J,
Phanouvong S, Harvey K, Hemming M. Moving from the known to the
unknown: From print to electronic Therapeutic Guidelines. ASCEPT
conference proceedings, Hobart, 1998. |
| McKinnon R, Harvey K.
Containing Vancomycin-resistant Enterococci: Strategies for
Victoria. (Conference Report) Victorian Drug Usage Advisory
Committee, Melbourne, 1999 |
| Harvey K. Teledisaster? A case
study of the recently abandoned Commonwealth Therapeutic Health
Information Project. Australian & New Zealand Health Services
Research Conference, 1999. |
| Harvey K. From optimising
antibiotic use to involvement in national medicinal drug and
health IT policy: issues relevant to decision support. General
Practice Computing Group Electronic Decision Support Workshop,
Canberra, 1999. |
| Harvey K. Exporting Australian
E-Health Expertise. AIC Worldwide Conferences E-Health, Sydney,
1999. |
| Harvey K. Therapeutic Knowledge
Databases. SPIRT Pharmaceutical Decision Support Workshop,
Melbourne, 2000 |
| Harvey K. The SPIRT I
Pharmaceutical Decision Support Workshop. School of Information
Technology & Mathematical Sciences, University of Ballarat,
March 2000. |
| Harvey K. Medication Management
2000: e-Promotion, e-Scripts, e-Health? 2nd International Primary
Health Care Conference, Melbourne April 2000 |
| Harvey K. Pharmaceutical
Decision Support Systems. International Workshop on Enterprise
Networking and Computing in HealthCare Industry (Healthcom 2000),
Sydney, April 2000. |
| Harvey K. The Doctors
Assistant: Decision Support. Mornington Peninsular Division of
General Practice, IT-Expo, 13-14th May 2000 |
| Harvey K. Information for
Decision Support: Therapeutics. NHIMAC National Health Online
Summit, 3-4 August 2000. |
| Harvey K. Pharmaceutical
Decision Support. Victorian Society of Hospital pharmacists of
Australia, 11 November, 2001. |
| Harvey K. Tensions in
Australian Medicinal Drug Policy: The Pharmaceutical Benefits
Advisory Committee Controversy. 2nd bilateral research
conference, Ateneo de Manila University and La Trobe University,
April 18-20, 2001 |
| Harvey K. National
Antibiotic Summit, Sydney. Workshop participant, 30 to 31
May, 2001. |
| Harvey K, Experts at Risk:
The Role of Advocacy and Science in the Development of Public
Health Policy: The PBAC controversy. Public Health
Association of Australia, ACT Branch, University House,
Australian National University, 18 June 2001. |
| Harvey K. Recent controversies
surrounding the Australian Pharmaceutical Benefits Scheme (PBS)
IIR s E-PHARMA Conference, Meridian Hotel, Sydney, 27- 29 June
2001. |
| Harvey K. How TNCs shape
Consumer Culture: The Case of Pharmaceuticals. Asia Pacific
Research Network (APRN) Conference - Corporate Power or Peoples
Power: TNCs and Globalization, Sydney, 27 September 2001 |
| Harvey K. Risky Business:
Improving Antibiotic Use in Australia. Keynote Address. Victorian
Infection Control Practitioners Association (VICPA) Conference,
15 November 2001. |
| Harvey K. Pharmaceutical
Decision Support. E-Health Workshop for Health Professionals. La
Trobe University, 23 November 2001. |
| Harvey K. TRIPS &
Pharmaceuticals in a public forum on GATS, TRIPS, Globalisation
and Public Health. The Victorian Public Health Association and
VicHealth, 14 March 2002. |
| Harvey K. Pharmaceutical
Decision Support, GnuMed conference, Lismore, NSW, 25-27 May
2002. |
| Harvey KJ. Meet a therapeutic
guideline activist, Meet the Expert Session, Improving
Medication Management Workshop, Department of Human Services,
Melbourne, November 2002 |
| Harvey KJ. Patient safety and
clinical risk management: the challenge of implementing
computerised prescribing and decision support systems. Key Note
Address. Society of Hospital Pharmacists of Australia Victorian
State Branch Conference, Bendigo, November 2002. |
| Harvey K, Zhang Y. Antibiotic
resistance. Infection Control Seminar, Gippsland Regional
Infection Control Group, La Trobe Valley Hospital, Tralagon,
November 2002 |
| Harvey K. Resistance to
Antibiotics. ABC Radio National Perspective, Thursday 12 December
at 5:55pm. |
| Harvey K. Meet the Expert
(Therapeutic Guidelines). Improving Medication Management
Workshop. Quality and Care Continuity Branch Metropolitan Health
and Aged Care Division, Department of Human Services, November
2002. |
| Harvey K. Update on Decision
Support and Guideline representation from HL7, Cleveland. Austin
Hospital Informatics - Work In Progress Seminar, June 2003. |
| Harvey K. Saving the
Pharmaceutical Benefits System. Fabian Society & Doctors
Reform Society, Trades Hall, Melbourne, June 2003. |
| Harvey K. Decision Support
Tutorial (invited) Health Informatics Conference, Sydney, August
2003. |
| Harvey K (panel member). The
Future of Open Knowledge in General Practice. GPCG Forum, Sydney,
August 2003. |
| Harvey K. The Need for
Decisions Support Standards - a User Perspective. HL7 Australia
Decision Support Conference, Sydney, August 2003. |
| Harvey K. Antibiotic
resistance. Infection Control Seminar, Gippsland Regional
Infection Control Group, Warrigal, November 2003. |
| Harvey K. Saving the
Pharmaceutical Benefits System. Health Economic Unit, Monash
University, Seminar, December 2003. |
| Harvey K. (Co-Chair) Workshop
background. HL7 Australia & New Zealand, Clinical Decision
Support Workshop, December 2003. |
| Harvey K. The Croatian
Pharmaceutical Reform Project. School of Public Health Seminar
Series, March 2004. |
| Harvey K. The FTA and the PBS:
Public Health & Consumer Concerns. Fabian and Doctors
Reform Society, Melbourne, July 2004. |
| Harvey K. International
experience with rational drug use. Jordan Food & Drug
Administration, Rational drug use workshop, Marriott Hotel, Dead
Sea, September, 2004 (Workshop
report PDF 66 kb). |
| Harvey K. Impact of
E-Prescribing on Antibiotic Use in Australia. American Society of
Microbiology Annual Meeting on Infectious Diseases (ICAAC
2004), Washington USA, October 2004. |
| Harvey K. The Australian
Pharmaceutical Benefits Scheme 1994-2004. United States
Pharmacopeia, Rockville, USA, November 2004. |
| Harvey K. Will the AUSFTA
undermine the PBS? Society of Hospital Pharmacists of Australia,
Victorian Branch, November 2004. |
| Harvey K. Cost containment in
Pharmaceutical Benefit Scheme, Australia at International
Conference on Cost Containment in National Health Insurance
System, Chaingmai, Thailand, 25-25 February 2005. See:
http://www.nhso.go.th/nhso/conference/.
|
| Harvey K. Pharmaceutical
promotion in prescribing software: an analysis. La Trobe
University, School of Public Health Research Seminar, March 2,
2005. Available (PDF
1.8 meg). See also response of Dr. Andrew Magennis, Medical
Director, HCN. (This was removed from this site at Dr. Magennis'
request on March 17, 2005) . |
| Harvey K. The PBS and Quality
Use of Medicines, Medication Management Review Workshop, La Trobe
University, Bendigo, March 19, 2005. |
| Harvey K. Free markets and
medical software. Fabian Society, Victorian Trades Hall, April 6
2005. Available (PDF
2.0 meg). |
| Harvey K. Promotional
practices: the need for action. Asia Health Forum, Universiti
Sains Malayia, Penang April 26, 2005 (PDF
1.04 meg). |
| Harvey K. Is the PBS
sustainable? Current problems; possible solutions? ALP Hawthorn
Branch, May 4, 2005 (PDF
953 kb); also Australian College of Pharmacy, Victorian
Fellows Dinner, May 19, 2005 (PDF
967 kb). |
| Harvey K. Profit driven
research: The problems. Cabrini Hospital Human Research Ethics
Committee Seminar, Who Profits from Research? June 2, 2005
(PDF
226 kb). |
| Harvey K. Critical assessment
of Jordan RDU & EDL within the International context.
Rational Drug Use workshop, PHRplus, Amman, Jordan, July 2005.
|
| Harvey KJ (Session Moderator &
Lead Presenter). Pharmaceutical promotion in medical software.
Health Informatics Conference August 2, 2005. |
| Harvey K. Does pharmaceutical
marketing unbalance the PBS? 3rd Future of the PBS Conference,
Informa, August 25, 2005. |
| Harvey K. Free Markets and
Medical Software. Monash Department of Epidemiology and
Preventative Medicine Research Seminar, September 21, 2005. |
| Harvey K. From Victorian State
Antibiotic Guidelines to Australian Quality Use of Medicines
Policy & The Australian Pharmaceutical Benefits Scheme:
Ensuring equitable access to necessary medicines for rich and
poor. 2nd National Workshop on Rational Use of Antibiotics in
China, Beijing, November 28-30, 2005. |
| Harvey K. Curbing
Pharmaceutical Promotion: (fighting the commercialization of
health). HAIAP Seminar, GK, Dhaka, Bangladesh, April 10-12,
2006.
Harvey K. The reporting of medicines in the media:
research findings. National Prescribing Service Seminar for
Health and Medical Writers, Sydney, May 3, Canberra, May 31,
2006. |
| Harvey K. Electronic medication
management. 2nd Annual eHealth Conference, 31st July-2nd August,
2006.
Harvey K, Sweet G, Horsfall B. Evidence vs hype:
informing better prescribing. National Prescribing Service
Dandenong - District Division of General Practice, May 6, 2006,
June 20, 2006; Greater South Eastern Division of General
Practice, August 30, September 4, 6, 28, 2006. |
| Harvey K. Australian Private
Health Insurance: Inclusive and Equitable? International Society
for Equity in Health Meeting, Adelaide September 11, 2006. |
| Harvey K. Drug Formularies and Rational Drug Use; The Role
of Pharmacy & Therapeutic Committees; Drug Evaluation. Jordan
National Drug Formulary Dissemination and Implementation Strategy
Workshop & PTC Training Workshops, Amman, Jordan, September
18-20, 2006 |
| Harvey K. Complementary therapies: What every consumer
with a chronic illness should know. Chronic Illness Alliance AGM,
13 December 2006. |
| Harvey K. Private Health Insurance Controversies. U3A Hawthorn
Summer School, 12 January 2007; U3A Stonnington, 28 March, 2007. |
| Harvey K. A Sustainable Pharmaceutical Benefits Scheme. U3A Hawthorn
Summer School, 19 January 2007; U3A Stonnington, 4 April, 2007. |
| Harvey K. Electronic Health Records. U3A Hawthorn
Summer School, 26 January 2007; U3A Stonnington, 11 April, 2007. |
| Harvey K. The 4th Annual Future of the PBS Conference. Conference Chair & Changes in health: a snapshot on prevalent therapeutic drug requirements - Informa Pty. Ltd. 30 April, 2007. |
| Harvey K. Antibiotic resistance and antibiotic use. Monash Medical School. R1, May 18, 2007. |
| Harvey K. Complementary and Alternative Medicine. U3A
Manningham July 23, 2007. |
| Harvey K, Korczak V, Marron L, Newgreen D. Complementary
Medicine: Commercialism, choice and consumer protection. School of
Public Health Research Seminar, La Trobe University, 15 August,
2007. |
| Harvey K. Debating Globalisation: Medicinal Drug Policy.
Menzies College, La Trobe University, August 20, 2007. |
| Harvey K. The Crises in Health Funding – Sustainability of the
PBS. Yarra Valley U3A, La Trobe University, September 27, 2007. |
| Harvey K. Medicinal Drug Policy. Flinders University,
Adelaide, October 19, 2007. |
| Harvey K. Complementary Medicine: Commercialism, choice and
consumer protection. U3A Hawthorn Summer School, January 16, 2008. |
| Harvey K, Transparency and the PBS. The 5th Annual
Future of the PBS Conference. Informa Pty. Ltd. May 7, 2008. |
| Smith A, Williamson M, Sweidan M, Harvey K, Reeve J. Building
consensus on features supporting safety, quality and usefulness of
general practice prescribing software. National Medicines
Symposium, Canberra , May 15, 2008. |
| Harvey K. Transparency and the PBS. 5th Annual Future of the
PBS Conference, Informa, May 6, 2008. |
| Harvey K. Complementary Medicine Reform. National Medicines
Symposium, Canberra , May 16, 2008 |
| Harvey K. Complementary Medicine Reform, National Medicines
Symposium, May 16, 2006. |
| Harvey K. Complementary Medicine Reform. Blackmores, Sydney,
June 17, 2008. |
| Harvey K. Complementary Medicine Reform. St. Vincent's
Hospital, Sydney, August 15, 2008. |
| Harvey K. Australia-US Free Trade Agreement and the PBS.
HAIAP, Bangkok, August 25, 2008. |
| Harvey K. E-Health, Patients and Ethics. HIC08, Melbourne,
Sept 1, 2008 |
Other printed
publications
Publication in other
media
Radio
Film
| ABC and BBC Horizon program.
The Microbe Masters the Mould. A 50 minute scientific
documentary film on antibiotic resistance, 1986. |
| WHO Drug Action Program. Prescribing rationally, not
fashionably. An Australian video produced in association with
Dr. Frances Black (RACGP-FMP Educator). An Indian version, Push,
Promote or Educate? was also produced in association with
Prof. CH Shasindran and Prof. KR Sethuraman, of the Jawaharlal
Institute of Postgraduate Medical Education and Research,
Pondicherry, India |
CDROM
| Norquay C, Dartnell J, Phanouvong S, Harvey K. (electronic
conversion authors) E-Antibiotic
Guidelines (HTML Help format) 10th Ed. 1999
Therapeutic Guidelines Ltd., Melbourne 1999, (and later). |
World Wide Web (WWW)
| Coulthart R, Harvey K, et al. The Doctor's Gravy Train, Nine Network Australia Sunday
Program, August 5, 2001
http://news.ninemsn.com.au/sunday/cover_stories/article_896.asp
|
| Harvey K, The Pharmaceutical
Benefits Scheme (Nov 2, 2001) Digest
http://www.australianreview.net/digest/2001/11/harvey.html
|
| Harvey K, Symposium: The 2002-03 Federal Budget - Securing the future of the PBS? (June
3 2002) Digest
http://www.australianreview.net/digest/2002/06/harvey.html
|
| Harvey K. Pharmaceutical
benefits and free trade: trouble ahead for subsidised medicines
in Australia? (March 19, 2004) Digest
http://www.australianreview.net/digest/2004/03/harvey.html
|
| Harvey K. Private Health Insurance: Where are
we now and where should we be going? 22 February 2006.
http://cpd.org.au/article/private-health-insurance%3A-where-are-we-now-and-where-should-we-be-going%3F
|
| Harvey K. The Sale of Medibank Private.1 March 2006.
http://cpd.org.au/article/sale-medibank-private
|
| Harvey K. Drug companies' free lunches have expensive
side-effects, 4 August, 2006.
http://cpd.org.au/article/drug-companies%2526%2523039%3B-free-lunches-have-expensive-side-effects
|
| Harvey K. Policy Change Needed for Complementary Medicines.
Insight, August 2008.
http://cpd.org.au/article/policy-change-needed-complementary-medicines
|
|
